drugset
drugset / Trial / NCT07015528

Assessment of Drug Liking In Peri-procedural Clinical Settings

NCT07015528 ↗

Phase 0 Enrolling by invitation 130 enrolled Stanford University
RandomizedParallel-groupTriple-blindOther

Summary

The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.

Timeline

Start
2025-09-30
Primary completion
2026-08-31
Completion
2027-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Droperidol Small molecule — Intravenous

Indications

No indication recorded.